Methods of reducing porcine circovirus-associated disease outbreaks
AssigneeBoehringer Ingelheim Vetmedica GmbH
InventorJohn Kolb
Life of this patent
Estimating the term…
Abstract
The present invention relates to the use of an immunogenic composition that comprises a salmonella antigen for treatment of several clinical manifestations (diseases). Preferably, the clinical manifestations are associated with a PCV2 infection, even more preferably PCVAD. The use relates to a method comprising the steps of administering the composition to an animal in need thereof, preferably prior to disease exposure. Administration of salmonella antigen, preferably a salmonella vaccine, lessens the incidence and reduces the severity of PCVAD.
Claims11
A method of reducing the incidence of or lessening the severity of clinical symptoms associated with PCVAD, lessening the overall porcine circovirus load of an animal, or reducing the immunosuppressive effect of porcine circovirus infection comprising the step of administering a salmonella antigen to a pig.
A process for the production of a medicament for reducing the incidence of or lessening the severity of clinical symptoms associated with PCVAD, lessening the overall porcine circovirus load of an animal, or reducing the immunosuppressive effect of porcine circovirus infection, said process comprising the steps of obtaining a salmonella antigen, and combining said antigen with veterinary-acceptable carriers, pharmaceutical-acceptable carriers, or immunomodulatory agents.
A method of reducing PCVAD comprising the step of administering to a swine an effective amount of a salmonella antigen.
Dependencies are inferred from the claim text.